Category 

Life Sciences

Filter
Filter
Sector
All Sectors
Location
All Locations
Country
All Countries
Reset all
Unlocking the full story of every cell.
Spotlight
Unlocking the full story of every cell.
Zafrens exists to bring the life sciences to the AI era using cutting edge engineering tools. The costs and pace of data generation in biology/chemistry lag behind our ability to process data by many, many orders of magnitude. Zafrens aim to bridge this gap by developing ultra-high throughput, ultra-high resolution approaches to studying cells, both at the single-cell level and in the context of cell-cell interactions in various co-cultures. Considering the quickest way to understand complex systems is to perturb them, and thus the team have built a versatile platform that allows us to probe profound, complex questions by simply swapping the inputs to the system.
Zafrens
Life Sciences, Health Tech / America, USA / Seed
Zafrens
Unlocking the full story of every cell.
Life Sciences
America
USA
Seed
Engineering cells to make better mRNA.
Spotlight
Engineering cells to make better mRNA.
The future of mRNA technology is hampered by manufacturing challenges and unless solved, its exciting potential may never be realised. Sensible Biotechnologies is on a journey to solve this problem by turning living cells into factories producing abundant, highly stable and non-immunogenic mRNA on demand.
Sensible Bio
Life Sciences, SynBio / Europe, England / Seed
Sensible Bio
Engineering cells to make better mRNA.
Life Sciences
Europe
England
Seed
Turning drug discovery into a search query
Spotlight
Turning drug discovery into a search query
At Enveda, they are systematically translating molecules found in medicinal plants into new drugs for challenging diseases. This platform harnesses nature's complexity with the help of cutting-edge advancements in knowledge graphs, machine learning, and metabolomics. Enveda is starting a movement to create the next generation of small molecule therapeutics.
Enveda Bioscience
Life Sciences, Tech Bio / America, USA / Series B
Enveda Bioscience
Turning drug discovery into a search query
Life Sciences
America
USA
Series B
Revolutionising 3D cell biology.
Spotlight
Revolutionising 3D cell biology.
With a strong foundation of fundamental research, Inventia has developed a proprietary platform encompassing drop-on-demand bio-printing technology, an expanding library of printable matrices and custom protocols for specific applications. The RASTRUM platform is now available to enable efficient and powerful bio-printing of 3D cell-based assays for biomedical research.
Inventia
Life Sciences, / Australia/NZ, Australia / Series B
Inventia
Revolutionising 3D cell biology.
Life Sciences
Australia/NZ
Australia
Series B
Fermenting sustainable protein for human food using renewable methanol and bioreactors.
Spotlight
Fermenting sustainable protein for human food using renewable methanol and bioreactors.
Farmless want to create a hopeful future by decoupling food production from arable land. They do this by cutting out the middle man of photosynthesis and replacing it with renewable energy to grow microbial protein with methanol as a feedstock. Farmless can do this with 100-500x less land compared to animal proteins and 10-100x less land compared to plant proteins, independent from climate in a sustainable way.
Farmless
Life Sciences, / Europe, Netherland / Pre-Seed
Farmless
Fermenting sustainable protein for human food using renewable methanol and bioreactors.
Life Sciences
Europe
Netherland
Pre-Seed
Concert Bio
Platform to discover, develop and unleash beneficial microbes for indoor farms to replace harmful pesticides.
Life Sciences
Europe
England
Pre-Seed
Personalised health analytics based on glucose monitoring.
Spotlight
Personalised health analytics based on glucose monitoring.
Hello Inside provides the user with intelligent, personalised insights based on their food intake and glycemic response (the effect that food or meal has on blood sugar levels after consumption - something that differs for each of us). The Continuous Glucose Monitoring patch has a small, sub-cutaneous needle which detects the glucose levels in blood and transmits the readings via bluetooth to any connected device. Hello Inside will leverage this technology to build a personalised health platform for consumers.
Hello Inside
Life Sciences, / Europe, Austria / Seed
Hello Inside
Personalised health analytics based on glucose monitoring.
Life Sciences
Europe
Austria
Seed
A "USB" for the human body, measuring biomarkers through sweat in real-time.
Spotlight
A "USB" for the human body, measuring biomarkers through sweat in real-time.
There are two parts to the Flow Bio system, a sensor made up of electrodes and micro-fluidics channels (this part is disposable), and a shell that holds the battery, electronics, RAM etc. Data is then displayed on a connected app where FlowBio's own data will be displayed and can be connected to other 3rd party data. The first biomarkers will be potassium, sodium and sweat rate to provide the most comprehensive and real-time view into hydration status.
Flow Bio
Life Sciences, / Europe, England / Pre-Seed
Flow Bio
A "USB" for the human body, measuring biomarkers through sweat in real-time.
Life Sciences
Europe
England
Pre-Seed
Algae platform to produce high-value ingredients for a broad range of industries and applications.
Spotlight
Algae platform to produce high-value ingredients for a broad range of industries and applications.
Provectus Algae is an Australia-based biotechnology company specializing in the optimization of microalgae species to produce high-value biobased chemicals, specialty ingredients, and biologics for use in a wide array of industries and applications. Provectus Algae enables groundbreaking capabilities with a well-balanced fusion of innovative proprietary technology and a thorough knowledge of the unique biological traits of microalgae. By leveraging advanced automation, machine learning, and synthetic biology approaches, Provectus Algae can rapidly develop, execute, and license biomanufacturing processes depending on the needs of their commercial partners.
Provectus Algae
Life Sciences, / Australia/NZ, Australia / Series A
Provectus Algae
Algae platform to produce high-value ingredients for a broad range of industries and applications.
Life Sciences
Australia/NZ
Australia
Series A
All natural meat alternatives developed with mushrooms.
Spotlight
All natural meat alternatives developed with mushrooms.
Fable’s founding team wanted to find a way to make it easier for people to transition to plant-based foods, and spoke to several chefs who suggested using mushrooms as a base ingredient. Fable use shitake mushrooms and have developed a unique methodology that enables them to utilise the mushroom’s stem for a delicious meat alternative.
Fable Food
Life Sciences, / Australia/NZ, Australia / Seed
Fable Food
All natural meat alternatives developed with mushrooms.
Life Sciences
Australia/NZ
Australia
Seed
Biotech inspired by nature
Spotlight
Biotech inspired by nature
Since the industrial revolution, advancements in manufacturing have enabled mass consumerism to grow exponentially. However consumers are quickly becoming aware of their impact on the environment, demanding more from brands. Enter synthetic biology. Soon we will be able to produce a large share of the global economy's physical materials, without compromising on performance and sustainability. Insempra bridges the gap between synbio R&D and scalable, industrial manufacturing for brands. We believe the Insempra team can accelerate the creation of sustainable alternatives to traditional materials and we’re excited to back them on their journey.
Insempra
Life Sciences, / Europe, Germany / Seed
Insempra
Biotech inspired by nature
Life Sciences
Europe
Germany
Seed
Organoids for precision health
Spotlight
Organoids for precision health
Imagine a world where drugs are tested not on animals but on actual human cells before they reach clinical trials. Imagine that every patient could receive therapeutics that are proven to be effective on that particular patient, not just the general population. This could save years of trial and error and patient suffering. We’re thrilled to back SUN Biosciences, who are building the foundations for this future by standardising organoid culture to build a single source of biological truth for drug testing, development and application. Their unique technology solves some of the core issues that have been holding organoids back.
SUN Bioscience
Life Sciences, / Europe, Switzerland / Seed
SUN Bioscience
Organoids for precision health
Life Sciences
Europe
Switzerland
Seed
Psychedelic inspired medicine
Spotlight
Psychedelic inspired medicine
Mental disorders account for one of the largest and fastest growing categories of the burden of disease worldwide. Mental ill-health has devastating effect on individuals, families and communities, and weighs heavily on societies and economies - the economic burden of mental ill-health can rise to up to 4% of GDP, and those with mental illness have poorer educational and work outcomes than those in good mental health. Psylo is building a proprietary platform for developing psychedelic medicines to redefine how we treat mental illness. The Psylo team is uniquely positioned to transform mental health treatment with the application of psychedelics. Collectively, they bring years of experience researching cannabinoids and building deep biotech companies. And, like all great company-builders, the founding team has assembled a supporting tribe of industry-leading biotech investors and psychedelic experts.
Psylo
Life Sciences, / Australia/NZ, Australia / Pre-Seed
Psylo
Psychedelic inspired medicine
Life Sciences
Australia/NZ
Australia
Pre-Seed
Normal
Real Meat Without Harm
Spotlight
Real Meat Without Harm
Meat has formed part of humankind’s diet since the first humans and still today, billions of people around the world consume meat on a daily basis. However the impacts on climate, animals, and the environment from producing meat in the 21st century is clearer than ever before. We can do better. Meatable is pioneering a way of producing real meat in a lab from cells in weeks, not years. Identical on every level without any of the drawbacks. Meatable’s patented opti-ox™ technology offers exciting cost efficiencies and the ability to build scalable meat production without the harm. We’re excited to watch Meatable build the future of food.
Meatable
Life Sciences, / Europe, Germany / Series A
Meatable
Real Meat Without Harm
Life Sciences
Europe
Germany
Series A
Normal
Not results found
Sorry, we couldn’t find any companies for your search.
Reset Filter